SARL NORAMEDIC : revenue, balance sheet and financial ratios

SARL NORAMEDIC is a French company founded 35 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in ESPALION (12500), this company of category PME shows in 2022 a revenue of 10.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL NORAMEDIC (SIREN 380453043)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C 10 001 228 € 11 063 136 € 8 532 402 € 8 305 939 € 8 178 230 € 8 520 974 €
Net income 225 661 € 73 183 € -54 € 285 530 € 162 053 € 245 580 € 144 364 € -13 964 € 61 108 €
EBITDA N/C N/C N/C 1 149 238 € 831 535 € 918 507 € 854 686 € 779 810 € 890 874 €
Net margin N/C N/C N/C 2.9% 1.5% 2.9% 1.7% -0.2% 0.7%

Revenue and income statement

In 2025, SARL NORAMEDIC generates positive net income of 226 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 61 k€ -> 226 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

225 661 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 81%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

80.807%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.217%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.5%

Solvency indicators evolution
SARL NORAMEDIC

Sector positioning

Debt ratio
80.81 2025
2023
2024
2025
Q1: 1.7
Med: 22.17
Q3: 81.11
Average

In 2025, the debt ratio of SARL NORAMEDIC (80.81) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.22% 2025
2023
2024
2025
Q1: 19.14%
Med: 38.79%
Q3: 62.8%
Average

In 2025, the financial autonomy of SARL NORAMEDIC (37.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 165.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

165.571

Liquidity indicators evolution
SARL NORAMEDIC

Sector positioning

Liquidity ratio
165.57 2025
2023
2024
2025
Q1: 116.06
Med: 197.47
Q3: 330.73
Average -24 pts over 3 years

In 2025, the liquidity ratio of SARL NORAMEDIC (165.57) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL NORAMEDIC

Positioning of SARL NORAMEDIC in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of SARL NORAMEDIC is estimated at 907 019 € (range 354 919€ - 2 759 888€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
69 tx
354k€ 907k€ 2759k€
907 019 € Range: 354 919€ - 2 759 888€
NAF 5 all-time

Valuation method used

Net Income Multiple
225 661 € × 4.0x = 907 019 €
Range: 354 920€ - 2 759 888€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare SARL NORAMEDIC with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about SARL NORAMEDIC

What is the revenue of SARL NORAMEDIC ?

The revenue of SARL NORAMEDIC in 2022 is 10.0 M€.

Is SARL NORAMEDIC profitable?

Yes, SARL NORAMEDIC generated a net profit of 226 k€ in 2025.

Where is the headquarters of SARL NORAMEDIC ?

The headquarters of SARL NORAMEDIC is located in ESPALION (12500), in the department Aveyron.

Where to find the tax return of SARL NORAMEDIC ?

The tax return of SARL NORAMEDIC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL NORAMEDIC operate?

SARL NORAMEDIC operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.